Navigation Links
Top 3 Clinical Research Organization Selects QTinno for a Phase I Drug Safety Trial
Date:11/29/2011

PRINCETON, N.J., Nov. 29, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiovascular diagnostic solutions developer, announced today that a top 3 Clinical Research Organization (CRO) will utilize QTinno®, automated cardiac safety solution, to support a Phase I drug safety study for a biopharmaceutical sponsor.  Fully automated ECG analysis, empowered by QTinno, will be delivered at the CRO's clinical pharmacology research unit under the terms of an existing Master Services Agreement with NewCardio.

NewCardio has been asked to install QTinno at the second of this CRO's Phase 1 units, enabling them to complete  an ongoing study for their biopharmaceutical sponsor. The study is expected  to provide more refined data compared to previous analysis conducted for the cardiac safety profile of the compound.  NewCardio expects to recognize the revenue from this study during the fourth quarter of 2011.

"The recommendation by the CRO to the sponsor to utilize QTinno for this Phase 1 study is recognition that QTinno provides accuracy and timeliness, at lower cost," said Vincent Renz, NewCardio's Chief Executive Officer.  "We are excited to have achieved this milestone, and look forward to this leading to additional business with the clinical resources provider and their sponsors in the future."

NewCardio's innovative 3-D ECG platform technology dramatically improves the accuracy and significantly increases the diagnostic value of the standard 12-lead ECG. NewCardio's lead product, QTinno, is a software suite that provides automated, comprehensive cardiac safety analysis as defined in the ICH E14 Guidance for Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. The Company believes that QTinno, based on NewCardio's technology and approach, is the industry's most advanced, validated solution for performing high quality, cost effective automated cardiac safe
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... N.J. , Aug. 1, 2014  PTC Therapeutics, ... on July 31, 2014 it approved non-statutory stock options ... common stock to seven new employees. The awards were ... a component of our new hires, employment compensation. ... Committee on July 31, 2014 and are being made ...
(Date:8/1/2014)... , Aug. 1, 2014  With monumental health reform ... speak a second language. Clinical efficacy is no longer ... under the ACA like PCORI are directing roughly $1 ... of new entities and environments, the federal healthcare ecosystem ... new language of outcomes and managed markets to the ...
(Date:8/1/2014)... YORK , Aug. 1, 2014  Valeant Pharmaceuticals ... L.P. today responded to the filing of a federal ... in California.  The complaint makes baseless claims about Valeant ... Allergan,s true purpose in bringing the litigation ... call a special meeting.  That purpose is made clear ...
Breaking Medicine Technology:PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 2Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 4Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 5Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 6
... 23, 2012  Doctors and other healthcare professionals have grown increasingly ... is taking with regard to Fosamax - a widely used ... fractures. The FDA has so far resisted ... prolonged use. Such labels are necessary in light of the ...
... BEIJING, Feb. 23, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical ... an emerging leader in the development, assembly, marketing and ... announced that for the year ended December 31, 2011, ... led by the Ministry of Science and Technology of ...
Cached Medicine Technology:Victims of Abnormal Bone Fractures Await Action as FDA Lingers on Edge of Tightening Fosamax Regulations 2Dehaier Medical Received Government Subsidy as a Certified High Technology Enterprise 2Dehaier Medical Received Government Subsidy as a Certified High Technology Enterprise 3
(Date:8/1/2014)... The "Antimicrobial Coatings Market by Type (Silver, ... Dioxide, and Zinc Omadine), Application (Indoor air/HVAC, Medical, ... Textiles, and others), & Geography (North America, Europe, ... to 2018" analyzes the Antimicrobial Coatings Market with ... the diverse geographical regions. , Browse 49 market ...
(Date:8/1/2014)... 1, 2014 (HealthDay News) -- Although many parents worry about ... a common choking hazard: food. Such was the ... cough after eating a handful of nuts. "At the ... if the coughing was related to his illness or choking," ... cold. A cashew had become lodged in his windpipe and ...
(Date:8/1/2014)... For years, proponents have praised breast-feeding as ... conducted by the Ohio State University, suggests that ... terms of their health and development, raising questions among ... their baby. So does this new research change the ... , chair of Pediatrics at Abington Memorial Hospital, not ...
(Date:8/1/2014)... 2014 (BRONX, NY) Scientists at Albert ... found that bacteria that aid in digestion help keep ... the journal Immunity , could yield new therapies ... of other disorders. , The research involved the intestinal ... of these microorganisms in promoting or preventing disease is ...
(Date:8/1/2014)... In today’s age, traditional learning methods are futile in ... methods need to be revamped, so that the necessary ... this age of the internet, online learning resources act ... management systems help in the planning, implementation, and assessment ... are proving to be very useful and this trend ...
Breaking Medicine News(10 mins):Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 2Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 3Health News:Antimicrobial Coatings Market Projected to Reach $2.9 Billion by 2018 – Report by MarketsandMarkets 4Health News:Food Is a Common Choking Hazard for Kids, Doctor Says 2Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 2Health News:Despite Recent Study, Abington Health Expert Encourages Breastfeeding 3Health News:'Normal' bacteria vital for keeping intestinal lining intact 2Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 4
... Dec. 13 (HealthDay News) -- In the aftermath of a ... the U.S. National Transportation Safety Board is recommending a nationwide ... devices, except in emergencies. According to media reports, the ... fatal pileup that occurred last year in Gray Summit, Mo. ...
... 14, 2011Caffeine is regarded by some as being a potent ... exercise performance. A range of expert opinions capture the scope ... in Journal of Caffeine Research , a quarterly peer-reviewed ... available online at www.liebertpub.com/jcr . Led by ...
... WASHINGTON -- A new Institute of Medicine report specifies ... Administration should require before allowing tobacco companies to sell ... of reducing the health risks of tobacco use. ... of a comprehensive strategy to lower tobacco-related death and ...
... an animal model is a difficult task, but Thomas ... Reporting in the Proceedings of the ... immunologists found that a specialized "human immune system" mouse model ... tick-borne infection known as relapsing fever, caused by the bacteria ...
... of its ongoing efforts to ensure safe, effective and ... joined the ABIM Foundation and eight other medical specialty ... choices by physicians and patients to improve health outcomes, ... dollars. The ACR will develop a list ...
... German . Compared to Neanderthals, modern humans have ... lobes and olfactory bulbs also suggest a combined use of ... of brain size is intimately linked to the evolution of ... independently evolved brains of roughly the same size but with ...
Cached Medicine News:Health News:U.S. Safety Board Urges Nationwide Ban on Drivers' Use of Cellphones 2Health News:New report identifies research needed on 'modified risk' tobacco products 2Health News:New report identifies research needed on 'modified risk' tobacco products 3Health News:Jefferson researchers mirror human response to bacterial infection and resolution in mice 2Health News:ACR in Choosing Wisely campaign to promote wise use of resources among physicians and patients 2Health News:Follow your nose 2
... is powerful, lightweight, easy ... soft, durable foam silicone ... covered by machine washable ... headband easily adjusts to ...
... is powerful, lightweight, easy ... soft, durable foam silicone ... covered by machine washable ... headband easily adjusts to ...
Solarc surgical headlight is durable, comfortable, lightweight and delivers the bright, white light expected from a xenon system, but at a fraction of the cost....
View Mex-3 is designed for out-patient surgery, hospital rounds and house calls....
Medicine Products: